clevidipine has been researched along with Coronary Artery Vasospasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayesta, A; Cuevas-Pérez, J; Fernández-Asensio, R; Iglesias-Fraile, L; Junco-Vicente, A; Persia-Paulino, YR | 1 |
| Meyer, T; Patel, M; Tharakan, A; Tobias, JD | 1 |
2 other study(ies) available for clevidipine and Coronary Artery Vasospasm
| Article | Year |
|---|---|
Malignant coronary vasospasm refractory to nitrates: Using clevidipine as an emergent coronary vasodilator.
Topics: Coronary Angiography; Coronary Vasospasm; Humans; Nitrates; Pyridines; Vasodilator Agents | 2022 |
Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting.
Topics: Aged; Calcium Channel Blockers; Coronary Artery Bypass; Coronary Vasospasm; Female; Half-Life; Humans; Intraoperative Care; Mammary Arteries; Pyridines; Radial Artery | 2012 |